Description: Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China. The company offers Mailuoning injection for the treatment of thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and sequelae, multiple arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and treatment of iron deficiency anemia; and lentinan injection for treatment of malignant tumors. It also provides medical health care services. Jinling Pharmaceutical Company Limited is based in Nanjing, China.
Home Page: www.jlyy000919.com
No. 58 Xingang Avenue
Nanjing,
210058
China
Phone:
86 25 8311 8514
Officers
| Name | Title |
|---|---|
| Mr. Yajun Chen | Vice Chairman and Pres |
| Mr. Yang Wang | VP & Chief Accountant |
| Mr. Sheng Chen | VP & Non-Independent Director |
| Mr. Jian Wang | VP |
| Mr. Jun Yang Xu | Sec. |
| Mr. Jian Biao Yin | VP |
| Quan Li | Pres Assistant |
| Jian Li | Pres Assistant |
| Mr. Ning Zhang | Assistant to the Pres |
| Mr. Xinning Zhu | Assistant to Pres |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 34.0435 |
| Price-to-Book MRQ: | 1.7684 |
| Price-to-Sales TTM: | 1.7548 |
| IPO Date: | 1999-08-27 |
| Fiscal Year End: | December |
| Full Time Employees: | 4865 |